The Gabelli Healthcare & Wellness Trust (NYSE:GRX) Short Interest Down 35.4% in August

The Gabelli Healthcare & Wellness Trust (NYSE:GRX) saw a large drop in short interest during the month of August. As of August 31st, there was short interest totaling 4,191 shares, a drop of 35.4% from the August 15th total of 6,492 shares. Based on an average daily trading volume, of 32,325 shares, the days-to-cover ratio is presently 0.1 days.

The Gabelli Healthcare & Wellness Trust Price Performance

Shares of The Gabelli Healthcare & Wellness Trust stock traded down $0.04 on Friday, hitting $9.62. The stock had a trading volume of 10,518 shares, compared to its average volume of 26,968. The business’s 50 day moving average is $9.83 and its two-hundred day moving average is $9.42. The Gabelli Healthcare & Wellness Trust has a twelve month low of $8.80 and a twelve month high of $10.20.

The Gabelli Healthcare & Wellness Trust Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Wednesday, September 16th will be paid a $0.17 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $0.68 annualized dividend and a yield of 7.1%.

Insider Activity at The Gabelli Healthcare & Wellness Trust

In related news, major shareholder Saba Capital Management, L.P. purchased 4,340 shares of the firm’s stock in a transaction that occurred on Thursday, August 27th. The shares were acquired at an average price of $10.05 per share, for a total transaction of $43,617.00. Following the purchase, the insider owned 2,155,133 shares in the company, valued at approximately $21,659,086.65. This represents a 0.20% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Over the last ninety days, insiders have bought 37,832 shares of company stock worth $382,333.

Institutional Investors Weigh In On The Gabelli Healthcare & Wellness Trust

A number of large investors have recently added to or reduced their stakes in the stock. Sit Investment Associates Inc. increased its position in shares of The Gabelli Healthcare & Wellness Trust by 23.7% in the fourth quarter. Sit Investment Associates Inc. now owns 1,031,350 shares of the investment management company’s stock worth $9,932,000 after purchasing an additional 197,594 shares during the period. Gamco Investors INC. ET AL lifted its holdings in shares of The Gabelli Healthcare & Wellness Trust by 1.1% during the 1st quarter. Gamco Investors INC. ET AL now owns 346,026 shares of the investment management company’s stock worth $3,132,000 after acquiring an additional 3,800 shares during the period. Blue Bell Private Wealth Management LLC boosted its position in shares of The Gabelli Healthcare & Wellness Trust by 5.3% during the 4th quarter. Blue Bell Private Wealth Management LLC now owns 292,672 shares of the investment management company’s stock worth $2,818,000 after acquiring an additional 14,814 shares in the last quarter. Aviance Capital Partners LLC increased its stake in The Gabelli Healthcare & Wellness Trust by 2.1% in the first quarter. Aviance Capital Partners LLC now owns 171,325 shares of the investment management company’s stock valued at $1,550,000 after acquiring an additional 3,482 shares during the last quarter. Finally, Uhlmann Price Securities LLC boosted its holdings in shares of The Gabelli Healthcare & Wellness Trust by 22.0% in the 1st quarter. Uhlmann Price Securities LLC now owns 61,590 shares of the investment management company’s stock valued at $557,000 after purchasing an additional 11,088 shares in the last quarter.

About The Gabelli Healthcare & Wellness Trust

The Gabelli Healthcare & Wellness Trust (NYSE: GRX) is a closed-end management investment company that seeks both capital appreciation and current income. The trust primarily invests in equity and equity-related securities of companies operating in the healthcare and wellness sectors. Trading on the New York Stock Exchange under the symbol GRX, the fund provides investors with exposure to growth opportunities in healthcare through its closed-end structure.

The trust’s portfolio is diversified across a broad range of healthcare sub-industries, including pharmaceuticals, biotechnology, medical devices, and healthcare services.